{
  "title": "Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function",
  "doi": "10.1016/j.mce.2006.04.012",
  "summary": null,
  "description": "Depot gonadotropin releasing hormone (GnRH) agonist (GnRHa) therapy is the treatment of choice for patients with\ncentral precocious puberty (CPP). It is still unclear whether long-term exposure to GnRHa is associated with\nimpaired reproductive function in adulthood.\nThe present study was performed on 46 women, former CPP patients, 12.5 Â± 3.7 years after the discontinuation of\ntreatment with depot GnRHa. In a structured interview, we assessed general health status, clinical signs possibly\nassociated with hyperandrogenism, menstrual cycle, gynaecological diseases and reproductive function. It appears\nthat long-term treatment with depot GnRHa is safe and does not impair reproductive function. The risk of former CPP\npatients to develop hirsutism and/or polycystic ovary syndrome does not seem to be increased compared to the normal\npopulation but this issue needs to be addressed in further long-term follow-up studies.",
  "tags": [
    "Precocious puberty"
  ]
}